STOCK TITAN

LifeVantage Declares Quarterly Dividend

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
dividends

LifeVantage (Nasdaq: LFVN), a health and wellness company focusing on cellular-level health products, has announced a quarterly dividend payment. The company's Board of Directors has approved a cash dividend of $0.04 per share of common stock. The dividend will be paid on March 17, 2025, to stockholders of record as of the close of business on March 3, 2025.

LifeVantage (Nasdaq: LFVN), un'azienda nel settore della salute e del benessere specializzata in prodotti per la salute a livello cellulare, ha annunciato un pagamento di dividendo trimestrale. Il Consiglio di Amministrazione della società ha approvato un dividendo in contante di $0.04 per azione di azioni ordinarie. Il dividendo sarà pagato il 17 marzo 2025 agli azionisti registrati alla chiusura degli affari del 3 marzo 2025.

LifeVantage (Nasdaq: LFVN), una empresa de salud y bienestar que se centra en productos de salud a nivel celular, ha anunciado un pago de dividendo trimestral. La Junta Directiva de la empresa ha aprobado un dividendo en efectivo de $0.04 por acción de acciones ordinarias. El dividendo se pagará el 17 de marzo de 2025 a los accionistas registrados al cierre de negocios del 3 de marzo de 2025.

라이프밴티지 (Nasdaq: LFVN)은 세포 수준의 건강 제품에 중점을 둔 건강 및 웰빙 회사로, 분기 배당금 지급을 발표했습니다. 회사의 이사회는 주당 $0.04의 현금 배당금을 승인했습니다. 배당금은 2025년 3월 17일에 지급되며, 2025년 3월 3일 영업 종료 시점의 주주에게 지급됩니다.

LifeVantage (Nasdaq: LFVN), une société de santé et de bien-être axée sur des produits de santé au niveau cellulaire, a annoncé un paiement de dividende trimestriel. Le Conseil d'Administration de la société a approuvé un dividende en espèces de 0,04 $ par action d'actions ordinaires. Le dividende sera payé le 17 mars 2025 aux actionnaires inscrits à la clôture des affaires le 3 mars 2025.

LifeVantage (Nasdaq: LFVN), ein Unternehmen im Gesundheits- und Wellnessbereich mit Fokus auf zelluläre Gesundheitsprodukte, hat eine vierteljährliche Dividendenzahlung angekündigt. Der Vorstand des Unternehmens hat eine Bartendezinszahlung von 0,04 USD pro Aktie der Stammaktien genehmigt. Die Dividende wird am 17. März 2025 an die zum Geschäftsschluss am 3. März 2025 registrierten Aktionäre ausgezahlt.

Positive
  • Maintaining regular quarterly dividend payments, indicating financial stability
  • Commitment to shareholder returns through cash distributions
Negative
  • None.

SALT LAKE CITY, Feb. 05, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of $0.04 per share of common stock, which will be paid March 17, 2025 to all stockholders of record at the close of business on March 3, 2025.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the newest MindBody GLP-1 System™, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System®, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.

Cautionary Note Regarding Forward Looking Statements

This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as "believe," "will," "hopes," "intends," "estimates," "expects," "projects," "plans," "anticipates," "look forward to," "goal," “may be,” and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. The declaration and/or payment of a dividend during any quarter provides no assurance as to future dividends, and the timing and amount of future dividends, if any, could vary significantly in comparison both to past dividends and to current expectations. Examples of forward-looking statements include, but are not limited to, statements we make regarding expected financial performance, including revenue and margins, executing against and the benefits of our key initiatives, future growth, including geographic and product expansion, expected financial performance, and expected dividend payments in future quarters. Such forward-looking statements are not guarantees of performance and the Company's actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company's current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, further deterioration to the global economic and operating environments, as well as those discussed in greater detail in the Company's Annual Report on Form 10-K and the Company's Quarterly Report on Form 10-Q under the caption "Risk Factors," and in other documents filed by the Company from time to time with the Securities and Exchange Commission (the “SEC”). The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.

Investor Relations Contact:

Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com


FAQ

What is the amount of LifeVantage's (LFVN) quarterly dividend for March 2025?

LifeVantage's quarterly dividend for March 2025 is $0.04 per share of common stock.

When is the payment date for LifeVantage's (LFVN) March 2025 dividend?

The dividend payment date is March 17, 2025.

What is the record date for LifeVantage's (LFVN) March 2025 dividend?

The record date is March 3, 2025, at the close of business.

How often does LifeVantage (LFVN) pay dividends?

LifeVantage pays dividends on a quarterly basis.

Lifevantage Corp

NASDAQ:LFVN

LFVN Rankings

LFVN Latest News

LFVN Stock Data

243.06M
10.42M
16.71%
37.18%
1.53%
Packaged Foods
Pharmaceutical Preparations
Link
United States
LEHI